Grant Mitchell, MD, MBA, is Co-Founder and CEO of Every Cure. He is a seasoned entrepreneur, operator and investor in the areas of health, technology, and machine learning. He has launched multiple health tech companies and operated in the CEO role in life science and tech organizations. Previously, Dr. Mitchell was a Principal in Analytics at McKinsey & Company’s artificial intelligence division, QuantumBlack. There he led teams that pioneered the use of machine learning algorithms and real world evidence databases to predict health outcomes in subpopulations by drug type. Dr. Mitchell was an integral part of the effort to support Dr. Fajgenbaum in the search for the cure of his own rare disease, and further collaborated with Dr. Fajgenbaum on the CORONA project. Every Cure is the culmination of Dr. Mitchell and Dr. Fajgenbaum’s experience in rare disease research, drug repurposing, and advanced analytics. Dr. Mitchell earned a BA in economics from New York University, MD from the University of Pennsylvania, and MBA from the Wharton School
